Start-up biotechs engaged in a dealmaking frenzy in 2015, signing almost twice the number of alliances penned in 2014. Regenerative medicine technologies were the key drivers behind some of the most lucrative deals in the industry. Oncology and CNS partnerships also doubled from last year.
Regen Medicine Drives Big Uptick In 2015 Start-Up Dealmaking
Biotech start-ups cut deals at a rapid pace in 2015, signing almost twice the number of alliances done in 2014. Regenerative medicine was prominent in key partnerships.